ACIU
ACIU
NASDAQ · Biotechnology

Ac Immune Sa

Penny Stocks Biotech Stocks Healthcare Stocks
$2.19
+0.08 (+3.79%)
As of Nov 7, 2:14 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +985.8% upside
Low Target $21.93
Average Target $23.78
High Target $37.21
Current Price $2.19
Current
$2.19
Target
$23.78
$21.93 $23.78 avg $37.21
Scenario Analysis
Bear Case
$21.93
901.4%
Low target
Base Case
$23.78
+985.8%
Avg target
Bull Case
$37.21
+1,599.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.90
-43.8% from high
52-Week Low
$2.02
+8.7% from low
Target vs 52W High
$23.78
+509.7% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.16
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%